Background--Sphingosine-1-phosphate plays vital roles in cardiomyocyte physiology, myocardial ischemia-reperfusion injury, and ischemic preconditioning. The function of the cardiomyocyte sphingosine-1-phosphate receptor 1 (S1P 1 ) in vivo is unknown.
S1P is an integral constituent of high-density lipoproteins and has been demonstrated to causally contribute to several of their beneficial effects. 6, 7 Recently, we have shown that diminished S1P content in HDL from patients with coronary artery disease is a cause of HDL dysfunction and that raising HDL-S1P therapeutically restored HDL function. 7 Mechanistically, S1P can act as an intracellular signaling molecule and as an extracellular ligand for 5 G-proteincoupled receptors. Three are expressed in the heart (S1P 1 , S1P 2 , and S1P 3 ) and were shown to mediate the effects of S1P on different aspects of cardiomyocyte biology. [8] [9] [10] In experimental myocardial ischemia-reperfusion models, S1P generated endogenously by cardiac sphingosine kinases or administered exogenously prior to ischemia protects against reperfusion injury, whereas endogenous S1P mediates the cardioprotective effect of ischemic pre-and postconditioning. 8, 10, 11 Exogenous S1P has been shown to protect through nitric oxide produced following activation of the endothelial S1P 3 receptor, 12 whereas endogenous S1P required Akt activation by both S1P 2 and S1P 3 for efficient cardioprotection. 13 Mice deficient for S1P 2 or S1P 3 have no obvious cardiac phenotype except for the resistance of S1P 3 À/À mice to the bradycardic effect of the S1P analog fingolimod (Gilenya; Novartis). 14 The S1P receptor responsible for S1P-mediated preconditioning had not been identified prior to our study. In humans, S1P 1 gene polymorphisms have been associated with coronary artery disease and stroke, 15, 16 but addressing its physiological role in the heart in vivo has been hampered by the embryonic lethality of global S1P 1 knockout mice.
In this study, we have examined the role of S1P 1 in normal and pathophysiological cardiac function by generating mice with a cardiomyocyte-specific deletion. We provided evidence that S1P 1 is indispensable for normal cardiac function, ion homeostasis, activity of the Na + /H + exchanger NHE-1, and myofibrillar Ca 2+ sensitivity. Furthermore, we addressed the role of S1P 1 in myocardial ischemia-reperfusion injury and ischemic preconditioning (IP).
Methods Mice
Mice homozygous for a floxed S1P 1 allele 17 were crossed with C57Bl6J mice heterozygous for the Cre recombinase under the control of the a-myosin heavy chain (aMHCCre) 18 to obtain S1P 1 aMHCCre mice and littermate controls (S1P 1 flox/flox ).
All procedures followed were in accordance with institutional guidelines.
Imaging, Echocardiography, and In Vivo Hemodynamic Measurements
Magnetic resonance imaging was performed using a 7-T Bruker NMR spectrometer and 18 F-fluorodeoxyglucose positron emission tomography on a high-resolution small-animal camera (quadHIDAC; Oxford Positron), respectively. Highresolution echocardiography with quantitative 3-dimensional assessment of cardiac function was performed on an ultrasound device with frame rates up to 280 Hz (Philips Medical Systems). Left ventricular (LV) catheterization was performed in closed-chest anesthetized mice, as described previously, 19 with dobutamine administered via the cannulated left jugular vein accompanied by measurements of heart rate, maximal LV pressure, and the first derivative of LV pressure.
Cardiomyocyte Diameter, Fibrosis, Real-Time Polymerase Chain Reaction, and Western Blotting
The mean cardiomyocyte diameter was measured in 100 cardiomyocytes with longitudinally cut nuclei on periodic acid-Schiff-stained sections and interstitial fibrosis assessed on picrosirius red-stained sections with an image analysis program (KS 300; Zeiss). For gene expression, total RNA was isolated from the left ventricle, cDNA was synthesized using the Revert Aid First Strand cDNA Synthesis Kit (Qiagen), and real-time polymerase chain reaction was performed on a Bio-Rad CFX96 system using iQ SYBR Green. Relative gene expression was calculated by the 2 ÀDDCT method and normalized to GAPDH. For Western blotting, myocardial tissue was homogenized in RIPA buffer, run on SDS-PAGE, transferred to nitrocellulose membranes, and blotted with antibodies to phospholamban, which was phosphorylated at serine 16 and threonine 17, respectively, sarcoplasmic reticulum Ca 2+ ATPase 2a, junctin, and calsequestrin (for normalization). The electrochemiluminescence signal was quantified by a Bio-Rad ChemiDoc MP Imaging System. The phosphorylation level of cardiac myosin light chain 2, troponin I, and myosin-binding protein C was determined using the Pro-Q Diamond/Sypro Ruby staining kit (Molecular Probes), as described. 20 Briefly, proteins on gels were stained for 1 hour with Pro-Q Diamond to determine phosphoprotein expression and overnight with Sypro Ruby to measure total protein content. Signals were visualized using the LAS-4000 Image Reader (Fuji Science Imaging Systems) and analyzed using the manufacturer's Multi Gauge version 3.2 software. Phosphorylation levels of myofilament proteins in knockout hearts were expressed relative to those of controls.
Functional Characterization of Single Cardiomyocytes
Detailed methods are provided in Data S1. LV myocytes were isolated by enzymatic dissociation. Cell size and membrane capacitance of the isolated cardiomyocytes were similar in all genotypes.
Action potential recordings
Action potentials (APs) were recorded using the perforated patch-clamp technique using an Axopatch 200B amplifier (Molecular Devices). APs were filtered and digitized at 10 and 40 kHz, respectively. APs were elicited at 1 to 10 Hz by 3-ms, %1.29 threshold current pulses through the patch pipette.
Resting membrane potential; maximal AP amplitude; maximal upstroke velocity; AP duration at 20%, 50%, and 90% repolarization; and plateau amplitude were analyzed and averaged from 10 consecutive APs. i was obtained by correction of measured overall cellular fluorescence signals for contributions of mitochondrially compartmentalized indo-1. pH i was determined from calibration curves obtained with nigericin, and NHE-1-dependent proton flux was calculated from the rate of recovery of pH i following acid loading. The sarcoplasmic reticulum Ca 2+ content of cells was studied by 20 mmol/L caffeine application.
Intracellular concentration measurements

Sarcomere length shortening
Sarcomere length (SL) was measured using a fast Fourier transform algorithm of the video image (200 frames per second) of the contracting myocytes (IonOptix).
cAMP measurements
The LANCE cAMP kit (PerkinElmer) was used to determine cAMP concentrations using a Victor plate reader (Wallac; PerkinElmer). All experiments were performed in the presence of 0.05% bovine serum albumin and 500 lmol/L of isobutylmethylxanthine. Force measurements at different Ca 2+ concentrations were performed on single demembranated cardiomyocytes, as described previously. 20 Briefly, isolated 
Ischemia-Reperfusion Injury and IP
Ischemia-reperfusion injury and IP were performed, as described. 21 In brief, mice of either sex were anesthetized with pentobarbital (80 mg/kg IP) and subjected to 30 minutes of occlusion of the left anterior descending coronary artery and 120 minutes of reperfusion without and with prior IP by 1 cycle of 5 minutes of occlusion of the left anterior descending coronary artery and 10 minutes of reperfusion. At the end of the experiment, the coronary artery was reoccluded, and Evans blue was injected intravenously to delineate the area at risk. After euthanizing the mice by KCl infusion, hearts were excised and cut into 4 to 5 transverse slices, and the infarct size was quantified by triphenyl tetrazolium chloride staining.
Statistical Analysis
Overall survival curves were estimated using the Kaplan-Meier method, and differences between genotypes were compared by the log-rank test. The Wilcoxon test was used in all experiments with small to moderate sample sizes (<10). ANOVA followed by a Bonferroni post hoc test was used to test for significant differences among groups. For the invasive hemodynamic measurements ( Figure 2C ), 2-way repeated-measures ANOVA was used, and the indicated significant differences are from the omnibus test. Average data are presented as meanAESEM.
Values of P<0.05 were considered statistically significant.
Results
Impaired Cardiac Function in Mice Carrying a Deletion of S1P 1 in Cardiomyocytes generated mice deficient for S1P 1 specifically in cardiomyocytes (S1P 1 aMHCCre ). S1P 1 aMHCCre mice were born with the expected mendelian frequency and appeared indistinguishable from their controls (S1P 1 flox/flox littermates) at birth; however, S1P 1 aMHCCre mice began to die prematurely from 34 weeks on, with a median survival time of 45 weeks ( Figure 1A ). On autopsy, spontaneously deceased mice presented with enlargement of all cardiac chambers ( Figure 1B receptor gene expression in the normal adult mouse heart (C57Bl6) expressed relative to S1P 1 . *Statistical significance of S1P 1 (n=7, P<0.05). B, Representative heart pathology of an S1P 1 aMHCCre mouse aged 45 weeks and a littermate control. C, Representative echocardiography of an S1P 1 aMHCCre mouse aged 45 weeks and its littermate control under basal conditions and after stimulation with dobutamine. The table shows quantitative assessment of cardiac function under basal conditions (basal) and after intravenous stimulation with low-dose (10 lg/kg per minute) dobutamine by echocardiography in control and S1P 1 aMHCCre mice at 34 weeks (n=5 and n=7, respectively) and 48 weeks (n=5 and n=6, respectively). D, Cardiac magnetic resonance imaging (representative end-systolic and end-diastolic images) and quantification of cardiac function in S1P 1 aMHCCre mice aged 48 weeks and control mice (n=5 each; *P<0.05 vs control). E, Representative 18 Ffluorodeoxyglucose positron emission tomography images (whole body, cardiac short and long axes) of an S1P 1 aMHCCre and control mouse aged 31 and 48 weeks. Dobu indicates dobutamine; EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; HR, heart rate; LVM, left ventricular mass; S1P 1 , sphingosine-1-phosphate receptor 1; SV, stroke volume.
diastolic and end-systolic volumes, increased LV mass, and reduced ejection fraction and stroke volume. Serial 18 Ffluorodeoxyglucose positron emission tomography imaging excluded myocardial viability defects as a cause of impaired function ( Figure 1E ). Histomorphometry of the left ventricle revealed cardiac fibrosis in S1P 1 aMHCCre mice that increased with age but no alterations in cardiomyocyte size ( Figure 2A ). LV gene expression was altered in S1P 1 aMHCCre mice:
Expression of atrial natriuretic peptide and b-myosin heavy chain was increased %6-fold, expression of brain natriuretic peptide was increased 2-fold, and expression of modulatory calcineurin inhibitory protein 1 was increased %5-fold compared with controls ( Figure 2B ). Invasive cardiac catheterization was then performed to assess LV function in response to adrenergic stimulation in S1P 1 aMHCCre and control mice aged 38 to 40 weeks (Figure 2C ). Maximal rates of contraction and relaxation were reduced with increasing doses of dobutamine in S1P 1 aMHCCre mice, whereas heart rates and maximal LV pressure were similar to controls ( Figure 2C ). Similar observations were made in 19-26 weeks old mice ( Figure S1 ).
Reduced Ca To explore the role of S1P 1 at the single-cell level, APs, Ca 2+ i transients, and sarcomere shortening were examined in single cardiomyocytes from S1P 1 aMHCCre mice and littermate controls. APs elicited at 1 to 8 Hz were significantly prolonged in S1P 1 aMHCCre cardiomyocytes (to 140% for AP duration at 90% repolarization), whereas all other AP parameters were unchanged ( Figure 3A ). Furthermore, a substantial decrease in diastolic and systolic Ca Figure 3C ). Basal cAMP levels were increased in S1P 1 aMHCCre cardiomyocytes ( Figure 3D ), in agreement with the coupling of S1P 1 to G i and its inhibitory effect on adenylate cyclase. Despite the lower absolute Ca 2+ i values, no changes in diastolic or systolic sarcomere length (SL) or SL amplitude were observed in S1P 1 aMHCCre cardiomyocytes ( Figure 3E) ; however, the rate of SL shortening was reduced, and the shortening durations increased (time to 90% relaxation at 2 Hz in controls 103AE4 versus 120AE5 ms in S1P 1 aMHCCre ).
To test whether the preserved contractility of S1P regulatory myofilament proteins such as myosin light chain 2 and myosin binding protein C was clearly reduced and that of troponin I showed a similar trend ( Figure 4B ).
Protein levels of sarcoplasmic reticulum Ca 2+ ATPase 2a, junctin, and total and phosphorylated phospholamban were not altered (Table S1 ). Figure 5C , 5D and 5E). Consecutive treatment with the NHE-1 inhibitor cariporide did not diminish Na + i any further ( Figure 5F and 5G), suggesting that the effect was due to suppression of NHE-1 activity. Nevertheless, this experiment does not exclude the possibility of a "floor effect" below a certain Na + i level. Neither dimethylsphingosine nor W146 affected SL shortening ( Figure 5H ), completely resembling the phenotype of S1P 1 aMHCCre cardiomyocytes.
We then addressed whether stimulation with S1P affects contractile function in S1P 1 aMHCCre cardiomyocytes in the absence and presence of noradrenaline. In the absence of noradrenaline, S1P had no effect on SL in both control and S1P 1 aMHCCre cardiomyocytes ( Figure 5I ). In the presence of noradrenaline, S1P decreased SL amplitude and shortened time to 50% relaxation in control cardiomyocytes but failed to do so in S1P 1 aMHCCre cardiomyocytes ( Figure 5J ). Furthermore, S1P inhibited noradrenaline-mediated cAMP generation in control but not in S1P 1 aMHCCre cardiomyocytes ( Figure 5K ).
Consequently, exogenous S1P exerted an indirect negative inotropic effect through S1P 1 in line with this hallmark feature of G i -coupled receptors. These data are in agreement with previous studies showing attenuation of isoproterenol-induced cardiomyocyte contractility by S1P through adenylate cyclase inhibition and its reversal by pharmacological S1P 1 inhibition. 24, 25 In summary, S1P 1 activation by acute S1P stimulation reduced b-adrenergic contractility through adenylate cyclase inhibition, whereas continuous S1P 1 signaling by endogenous S1P was required for the maintenance of NHE-1 activity.
Loss of IP in S1P 1 aMHCCre Mice
Several studies have shown that cardiac S1P produced endogenously by sphingosine kinases mediates the cardioprotective effect of IP 8 ; however, the responsible S1P receptor has remained unknown. To test whether S1P 1 was involved, we compared the response to IP in S1P 1 aMHCCre and control mice. As expected, IP conferred cardioprotection in controls, but the cardioprotective effect was completely absent in S1P 1 aMHCCre mice ( Figure 6A ).
Infarct size without IP was similar in both groups ( Figure 6A ). The survival kinase Akt is known to be instrumental for the effectiveness of IP in rodents (see review 26). Interestingly, sphingosine kinase 1-deficient mice (Sphk1
) cannot be preconditioned and cannot activate Akt following IP. 23 Consequently, we examined Akt signaling during IP in S1P 1 aMHCCre and control mice and observed that Akt phosphorylation was clearly impaired in IP samples from S1P 1 aMHCCre mice compared with controls ( Figure 6B ). In contrast, there was no difference in basal Akt phosphorylation in noninjured hearts ( Figure S2 ). These data support and DMS on SL. I and J, SL shortening in the presence of exogenous S1P (100 nmol/L) under basal conditions and after stimulation with NA (100 nmol/L) with electrical pacing of 6 Hz. K, Cyclic AMP levels after NA stimulation without and with exogenous S1P (100 nmol/L) expressed as relative to basal in S1P 1 aMHCCre cardiomyocytes and their controls. All mice were aged 45 to 48 weeks. "N" represents the number of animals used for isolation of cardiomyocytes and "n" indicates the number of total observations in single cardiomyocytes. *Statistical significance to vehicle or controls, respectively (P<0.05). DMS, dimethylsphingosine; J NHE-1 , NHE-1-dependent proton flux; NA, noradrenaline; Na + i , intracellular Na + concentration; n.s., not significant; pH i , intracellular pH concentration; S1P 1 , sphingosine-1-phosphate receptor 1; SL, sarcomere length. the notion that S1P 1 is responsible for IP and exerts its cardioprotective effect through Akt.
Discussion
In our study, we identified that continuous S1P 1 signaling is necessary for the maintenance of NHE-1 activity and for dampening of the Ca 2+ sensitivity of the contractile apparatus.
The decrease in myofilament contractility caused by S1P 1 signaling most likely takes place through inhibition of adenylate cyclase, consistent with the ability of S1P 1 to inhibit cAMP formation through G i . This is conceptually supported by the validity of the reverse because activation of the adenylate cyclase pathway is well known to cause the Ca 2+ -sensitizing effect of many agents such as endothelin 1, noradrenaline, and levosimendan. 27 The functional correlates of this finding were the shortened diastolic and systolic SLs, the reduced rate of SL shortening, and the increased shortening durations in S1P 1 aMHCCre cardiomyocytes. Its biochemical manifestation was the reduced phosphorylation of myosin light chain 2, myosin binding protein C, and troponin I, which are all substrates for cAMP-activated protein kinase A. The source of S1P to continuously engage S1P 1 was of cardiomyocyte origin and was generated by sphingosine kinases (with the cautionary note that sphingosine kinase inhibition data with dimethylsphingosine should be confirmed by genetic evidence). In this scenario, the lower Ca i without changes in contractility, and lower Ca 2+ sensitivity has been identified as the underlying cause. 28 Although not shown directly in our study, the increase of cAMP in S1P 1 aMHCCre cardiomyocytes may be suppressing NHE-1 activity because cAMP is a wellknown inhibitor of NHE-1. 29, 30 In addition, S1P has been shown to stimulate Na + /H + exchange in thyroid cells. 31 Nevertheless, complex compensatory changes in response to S1P 1 deficiency during development should also be considered. A possible explanation (that needs experimental confirmation) of A B Figure 6 . Myocardial infarction and ischemic preconditioning in S1P 1 aMHCCre mice. A, Infarct size/area at risk (INF/AAR) in S1P 1 aMHCCre and control mice that underwent 30 minutes of coronary occlusion followed by 120 minutes of reperfusion without or with ischemic preconditioning (1 cycle of 5 minutes of occlusion and 10 minutes of reperfusion before occlusion). All mice were aged 18 to 20 weeks. *Statistical significance (P<0.05) between groups (2-way repeated measures ANOVA followed by Bonferroni). B, Akt phosphorylation (Ser473) in ischemic preconditioning samples of control and S1P 1 aMHCCre mice at the time of sacrifice after ischemia-reperfusion. S1P 1 indicates sphingosine-1-phosphate receptor 1. Figure 7 . Schematic of the role of S1P 1 in the heart. b1-AR indicates b1-adrenoreceptor; NCX, Na + /Ca 2+ exchanger; NHE-1, Na + /H + exchanger; S1P, sphingosine-1-phosphate; S1P 1 , sphingosine-1-phosphate receptor 1; Sphk1, sphingosine kinase 1; Sphk2, sphingosine kinase 2.
how this regulatory system may contribute to cardiac physiology is its potential ability to accommodate hemodynamic challenge by increasing Ca 2+ sensitivity through a reduction of endogenous S1P production and thus S1P 1 signaling; at the same time, lower S1P 1 signaling would suppress NHE-1 activity, thereby reducing Na + i and Ca 2+ i and providing an elegant in-built safe-guarding mechanism against excessive Ca 2+ sensitization (Figure 7) .
IP relies on endogenous S1P synthesis by sphingosine kinases (see review 8), but the S1P receptor mediating IP was unknown. In this study, we identified S1P 1 as the S1P receptor required for the cardioprotective effect of IP. In contrast, S1P 1 played no role in the susceptibility of the heart to regular ischemia-reperfusion injury without IP. The exact mechanisms by which S1P 1 mediates IP are unknown but should be sought in the signaling pathways common to S1P 1 and IP. S1P produced by sphingosine kinases is increased during and indispensable for IP 8 and acts by activating the reperfusion injury salvage kinase pathway and the survivor activating factor enhancement pathway and by decreasing the cardiomyocyte susceptibility to mitochondrial permeability transition pore opening (see review 26). The inability of S1P 1 aMHCCre mice to benefit from IP and their defective Akt activation during preconditioning are consistent with the lack of IP in Sphk1 À/À mice and their inability to activate the Akt pathway. 23 Therefore, S1P 1 /Akt signaling is essential for IP in mice ( Figure 7) . A recent study showed that cardiac S1P 1 was downregulated in isoproterenol-induced heart failure in rats and that its overexpression alleviated heart failure after myocardial infarction; the authors suggested downregulation of the b1-adrenoreceptor by its cointernalization with S1P 1 as possible cause. 32 We did not see any enhanced contractile response to b-adrenergic stimulation in S1P 1 aMHCCre , as one might expect if there were a pool of b1-adrenoreceptors constantly being cointernalized because of constitutive S1P 1 activity-a pool that should be available in surplus for signaling in its absence. In fact, the response of S1P 1 aMHCCre to badrenergic stimulation was even worse in vivo and unaffected in vitro. In support, 3 studies showed that long-term FTY70 treatment of mice (a regimen that is generally known to downregulate S1P 1 ) improved LV function and survival after myocardial infarction in mice and pigs. [33] [34] [35] According to our observations, downregulation of cardiomyocyte S1P 1 may have a beneficial role in heart failure because it would alleviate the compromised Ca 2+ sensitivity of the failing heart and lessen its Ca 2+ overload by subduing the pathologically elevated NHE-1 activity. Future studies in experimental models of heart failure are needed to address these questions. Clearly, the role of S1P and its receptors in cardiac function under physiological and pathophysiological conditions is an exciting new area of research that promises novel ramifications for cardiovascular medicine.
Supplemental Material
Methods
Functional Characterization of Isolated Cardiomyocytes (Detailed Methods)
Left ventricular myocytes were isolated from adult mice (aged 30-38 weeks) by enzymatic dissociation. Cell size and membrane capacitance of the isolated cardiomyocytes were similar in all genotypes (data not shown). The following parameters were measured as described before 
Reagents
Immunological detection of phospholamban (PLB), SERCA2a, calsequestrin and junctin and the fraction of PLB phosphorylated at serine 16 and at threonine 17 were determined as described
3
. We thank Dr. L.R. Jones, Indianapolis, for providing calsequestrin, SERCA2a and junctin antibodies. Other antibodies used for Western blotting were from Santa Cruz Biotechnology (p38, #sc-535) or from Cell Signaling (pERK1/2 (#9101), ERK1/2 (#4695) and pp38 (#9211)).
Mice
All mice used in the experiments were of similar age and either all male or age and sex-matched. In studies involving age-related phenomena (such as the progressive development of cardiomyopathy), the specific age of the examined mice has been 
Statistics
Overall survival curves were estimated using the Kaplan-Meier method and differences between genotypes were compared by the log-rank test. Average data are presented as mean±SEM in all figures but Fig. 6a where the median (minimum to maximum) has been shown. For all cellular (in vitro) and animal (in vivo) work, twosided ANOVA for multiple comparisons (repeated measurements) were used to test whether relationships were significantly different, a two-side paired Student's t-test was used to test for significant differences within groups (e.g. effect of a drug or echocardiographical measurements in the same animal before and after treatment) and a two-sided unpaired t-test to test for significant difference between two groups, depending on the existence of equal variances and normal distribution of data. MannValues of P<0.05 were considered statistically significant. In all echocardiographical measurements, the investigator was blinded to genotype and treatment. For in vitro experiments, sample size has been chosen based on own experience from in previous experiments 4 . For all in vivo experiments, sample size was based on established (literature) method-specific sample sizes and our own work on I/R and ischemic preconditioning 4 .
Supplemental Tables   Table S1 . 
